Cochrane Corner: Addition of Long-Acting Beta2 Agonists or Long-Acting Muscarinic Antagonists Versus Doubling the Dose of Inhaled Corticosteroids (ICS) in Adolescents and Adults With Uncontrolled Asthma With Medium-Dose ICS

被引：0
|
作者：
Baigel, Rachel [1 ]
Gregory, Ian [1 ]
机构：
[1] North Middlesex Hosp, London, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2024年 / 54卷 / 09期
关键词：
D O I：
10.1111/cea.14554
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：647 / 650
页数：4
相关论文
共 50 条
  • [21] Increased doses of inhaled corticosteroids versus addition of long-acting β2 agonists for treatment of asthma
    Choi, J.
    Oh, M.
    Lee, B.
    Choi, D.
    Jeung, Y.
    ALLERGY, 2010, 65 : 553 - 554
  • [22] Long-acting β2 agonists preferred to theophylline for nocturnal asthma uncontrolled by inhaled corticosteroids
    不详
    Drugs & Therapy Perspectives, 2001, 17 (19) : 7 - 11
  • [23] EFFICACY AND SAFETY OF LONG-ACTING BETA AGONISTS plus LONG ACTING MUSCARINIC ANTAGONISTS VS. LONG-ACTING BETA AGONISTS plus INHALED CORTICOSTEROIDS IN COPD: A META-ANALYSIS
    Villalobos, R. E.
    David-Wang, A.
    Magallanes, J.
    RESPIROLOGY, 2016, 21 : 177 - 177
  • [24] Addition to inhaled corticosteroids of long-acting beta - agonists versus anti-leukotrienes for chronic asthma
    Chauhan, Bhupendrasinh F.
    Ducharme, Francine M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (01):
  • [25] EFFICACY AND SAFETY OF LONG-ACTING BETA AGONISTS plus LONG ACTING MUSCARINIC ANTAGONISTS VS. LONG-ACTING BETA AGONISTS plus INHALED CORTICOSTEROIDS IN COPD: A META-ANALYSIS
    Villalobos, R. E.
    David-Wang, A.
    Magallanes, J.
    THORAX, 2016, 71 : A113 - A114
  • [26] Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
    Buhl, Roland
    FitzGerald, J. Mark
    Busse, William W.
    RESPIRATORY MEDICINE, 2018, 143 : 82 - 90
  • [27] Long-Acting β-Agonists (LABA) Combined With Long-Acting Muscarinic Antagonists or LABA Combined With Inhaled Corticosteroids for Patients With Stable COPD
    Horita, Nobuyuki
    Nagashima, Akimichi
    Kaneko, Takeshi
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (13): : 1274 - 1275
  • [28] COST AND DRUG UTILIZATION TRENDS IN INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS (ICS/LABA) FIXED-DOSE COMBINATIONS IN SPAIN
    Collar, J. M.
    Colas, C.
    VALUE IN HEALTH, 2018, 21 : S409 - S409
  • [29] The Effect of Extra Fine Medium-dose Inhaled Corticosteroid/Long-Acting Beta-2 Agonist/Long-Acting Muscarinic Antagonist (ICS/LABA/LAMA) on Distal Airway Indices Using Functional Respiratory Imaging in Patients With Symptomatic COPD on ICS/LABA
    Lavon, B. R.
    Guasconi, A.
    Georges, G.
    Bates, J. H.
    Galkin, D.
    Muchmore, P.
    Skloot, G. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [30] Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent Asthma
    Krishnan, Jerry A.
    Lazarus, Stephen C.
    Blake, Kathryn, V
    Sorkness, Christine A.
    Covar, Ronina
    Dyer, Anne-Marie
    Lang, Jason E.
    Lugogo, Njira L.
    Mauger, David T.
    Wechsler, Michael E.
    Wenzel, Sally E.
    Cardet, Juan Carlos
    Castro, Mario
    Israel, Elliot
    Phipatanakul, Wanda
    King, Tonya S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (03) : 372 - 380
12345